Please assess the completion status of the following clinical trial:

Trial Title: Comparison of Low Volume PEG-Asc and Lower Volume PEG-Asc With Bisacodyl

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: None
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* All patients between the ages of 20 and 75 years who were scheduled to undergo colonoscopy~Exclusion Criteria:~* aged more than 75 years.~* known or suspected gastrointestinal obstruction, Ileus~* severe heart failure~* uncontrolled hypertension (systolic pressure \> 170 mmHg, diastolic pressure \> 100 mmHg)~* severe constipation~* clinically significant electrolyte abnormalities~* any prior bowel resection, or significant gastroparesis.

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: 75 Years
- Healthy Volunteers: t

Study Arms:
- 2L Polyethylene glycols-Asc (Type: ACTIVE_COMPARATOR): 1 L of PEG containing ascorbic acid (PEG A) was taken at 8:00 pm on the day before the colonoscopy, followed by an extra 500 mL of water. The second 1-L of PEG containing ascorbic acid was taken 4 h before the colonoscopy examination, with an additional 500 mL of water. Each liter of preparation and the extra 500 mL water had to be consumed within 2 h of the procedure. All colonoscopies were performed between 9 am and 1 pm.
- 1L PEG-Asc plus bisacodyl (Type: ACTIVE_COMPARATOR): 10 mg bisacodyl at 9:00 pm on the day before the colonoscopy. Four hours before the colonoscopy examination, 1 L of PEG containing ascorbic acid was taken, followed by an additional 1 L of water. The preparation was completed 2 h before the examination. All colonoscopies were performed between 9 am and 1 pm.

Based on this trial design, predict the completion outcome and termination type (if applicable).